Sio Gene Therapies, Inc. (SIOX): Price and Financial Metrics
GET POWR RATINGS... FREE!
SIOX Stock Price Chart Interactive Chart >
SIOX Price/Volume Stats
| Current price | $0.45 | 52-week high | $0.86 |
| Prev. close | $0.46 | 52-week low | $0.23 |
| Day low | $0.44 | Volume | 289,200 |
| Day high | $0.46 | Avg. volume | 355,788 |
| 50-day MA | $0.41 | Dividend yield | N/A |
| 200-day MA | $0.35 | Market Cap | 33.11M |
Sio Gene Therapies, Inc. (SIOX) Company Bio
Sio Gene Therapies, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops gene therapies that transform the treatment of serious neurodegenerative diseases. Sio Gene Therapies serves customers worldwide.
Latest SIOX News From Around the Web
Below are the latest news stories about SIO GENE THERAPIES INC that investors may wish to consider to help them evaluate SIOX as an investment opportunity.
Have you been able to find a good deal on Sio Gene Therapies Inc.’s shares?A share of Sio Gene Therapies Inc. (NASDAQ:SIOX) closed at $0.44 per share on Tuesday, up from $0.44 day before. While Sio Gene Therapies Inc. has overperformed by 0.07%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SIOX fell by -67.41%, with highs and lows ranging […] |
The Sio Gene Therapies Inc. (SIOX) had a good session last reading, didn’t it?The share price of Sio Gene Therapies Inc. (NASDAQ:SIOX) rose to $0.31 per share on Tuesday from $0.30. While Sio Gene Therapies Inc. has overperformed by 2.67%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SIOX fell by -78.00%, with highs and lows ranging from $1.52 […] |
Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and DissolutionNEW YORK, Dec. 14, 2022 (GLOBE NEWSWIRE) -- Sio Gene Therapies Inc. (Nasdaq:SIOX) today announced that its Board of Directors has determined, after extensive and careful consideration of potential strategic alternatives, that it is in the best interests of the Company and its shareholders to dissolve the Company and liquidate its assets, including its subsidiaries. "After evaluating the Company's strategic options, the Board of Directors unanimously concluded that it is in the best interests of |
After Jumping 2.96% During The Past Week, Should You Still Buy Sio Gene Therapies Inc. (NASDAQ: SIOX)?Sio Gene Therapies Inc. (NASDAQ:SIOX)’s traded shares stood at 0.51 million during the last session, with the company’s beta value hitting 1.58. At the close of trading, the stock’s price was $0.32, to imply an increase of 0.95% or $0.0 in intraday trading. The SIOX share’s 52-week high remains $1.53, putting it -378.12% down since … After Jumping 2.96% During The Past Week, Should You Still Buy Sio Gene Therapies Inc. (NASDAQ: SIOX)? Read More » |
Sio Gene Therapies Inc. (SIOX) can excel with these strategiesIn Thursday’s session, Sio Gene Therapies Inc. (NASDAQ:SIOX) marked $0.32 per share, up from $0.31 in the previous session. While Sio Gene Therapies Inc. has overperformed by 2.96%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, SIOX fell by -79.28%, with highs and lows ranging from […] |
SIOX Price Returns
| 1-mo | 1.88% |
| 3-mo | 48.71% |
| 6-mo | 31.35% |
| 1-year | -43.71% |
| 3-year | -89.77% |
| 5-year | N/A |
| YTD | 3.45% |
| 2022 | -66.28% |
| 2021 | -53.60% |
| 2020 | -45.70% |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...